Clinical Trial Update: cfMSC Therapy for Diabetes [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 clinical trial investigating cfMSC Therapy for Type 2 diabetes mellitus. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• cfMSC Therapy (mesenchymal stem cell therapy)

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Type II Diabetes Mellitus | Phase 1, Phase 2 | Status: RECRUITING